Funders · Entity Annotation Prototype (beta)

5,089articles mentioning funders

9,137funder mentions

3,238distinct funders extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted funders

Showing 901–960 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.

Bayer1 Belfast Health & Social Care Trust1 Belfast Trust1 Belgian Defence1 Belgian Federal Agency for Occupational Risks1 Bellberry Human Research Ethics Committee1 Bellberry Limited1 Belmont Forum grant1 Berkshire Research Ethics Committee1 Betsi Cadwaladr University Health Board1 Bhutan Ministry of Health1 Biden-era contracts1 Big Lottery1 Bigpicture consortium1 Bili Project Foundation, Inc.1 BioNTech1 Bioethical Committee1 Biomedical and Scientific Research Ethics Committee1 Bliss charity1 Bloomberg1 Bloomsbury Research Ethics Committee1 Blue Cross Blue Shield of North Carolina1 Blue Cross and Blue Shield of Louisiana1 Board of Management1 Bombay Stock Exchange1 Br J Gen Pract 20251 Br J Sports Med 20251 Bradford Marie Curie Hospice1 Brazilian Clinical Trials Registry1 Brazilian Ministry of Health1 Brenden Mann Foundation1 Brent Health Matters1 Bridge grant1 Brierley Consultancy1 Bristol Myers Squibb1 British Academy of Film and Television Arts1 British American Tobacco1 British Association of Parenteral and Enteral Nutrition1 British Association of Perinatal Medicine1 British Broadcasting Corporation1 British Cardiovascular Intervention Society1 British Cardiovascular Society1 British Diabetic Association1 British Education Index1 British Elbow & Shoulder Society1 British Heart Foundation Clinical Research Collaborative1 British Heart Foundation Clinical Research Training Fellowship1 British Intestinal failure alliance1 British Journal of Nursing1 British Medical Association1 British Menopause Society1 British Neuropsychiatry Association1 British Nursing Database1 British Oculoplastic Surgical Society1 British Paediatric Sleep Society1 British Postgraduate Medical Federation1 British Pregnancy Advisory Service1 British Society for Allergy and Clinical Immunology1 British Society for Rheumatology1 British Society of Gastroenterology International Grant1

View all 3,238 funders on one page

Articles mentioning funders

5,089 articles · page 116 of 425

Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial

svnbmj · abstract · 2025-11-10 · 2 matching annotations

87.1%

NCT06429384 ChiCTR2400081662 Loberamisal AIS acute ischaemic stroke

…spective validation.Trial registration number ChiCTR2400081662, NCT06429384.…

Mesalamine for Colorectal Cancer Prevention Programme in Lynch syndrome (MesaCAPP): a multicentre, multinational, randomised, two-arm, double-blind, phase II clinical study with mesalamine or placebo in carriers with Lynch syndrome – a study protocol

bmjopen · abstract · 2025-11-09 · 2 matching annotations

86.8%

Swedish Research Council European Clinical Trials Information System ulcerative colitis Mesalamine CRC 5-ASA Lynch syndrome colorectal cancer LS colorectal neoplasia+1 more

…Regional Ethical Review Board in Stockholm and funding from the Swedish Research Council. The study protocol is the finalised V.10.0 (11 April 2024), tr…

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands

bmjopen · abstract · 2025-11-09 · 2 matching annotations

80.5%

EUCT Netherlands Central Committee on Research Involving Human Subjects neoadjuvant chemotherapy interval cytoreductive surgery EOC carboplatin

…t scientific conferences.Trial registration number NCT05773859; EUCT number 2024-512353-24-01.…

Pursuing Reduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER): a protocol for a randomised feasibility trial

bmjopen · abstract · 2025-11-09 · 2 matching annotations

76.3%

NCT06156176 Western University Health Sciences Research Ethics Board Long COVID COVID-19 COVIDEx intervention usual care

…ations and patient/community channels.Trial registration number NCT06156176…

Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova

bmjgh · abstract · 2025-11-08 · 2 matching annotations

89.3%

WHO mSTR MDR-TB multidrug-resistant tuberculosis SOC

…d Republic of Moldova. We used cohort data on mSTR efficacy and WHO data on SOC in patients with MDR-TB. We used a Markov model, wi…

1342 First-in-human dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and initial efficacy of mRNA-LNP MT-302 in vivo CAR therapy in solid tumors

jitc · abstract · 2025-11-07 · 2 matching annotations

84.7%

Myeloid Therapeutics ClinicalTrials.gov MT-302 solid tumors

…formed consent prior to enrollment. This trial was sponsored by Myeloid Therapeutics and conducted in collaboration with the participating investiga…

1346 Molecular and immunologic correlates of response in a phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma

jitc · abstract · 2025-11-07 · 2 matching annotations

93.6%

Merck NCI Merkel cell carcinoma pembrolizumab Lenvatinib H. Lee Moffitt Cancer Center & Research Institute MCC

…tance.Acknowledgements The authors acknowledge the support from Merck for support of the trial associated analysis of biospecimens. T…

Smoking cessation after referral from hospital to community stop smoking services: an observational study

bmjph · abstract · 2025-11-07 · 2 matching annotations

89.9%

NHS cancer

…Introduction In England, acute National Health Service (NHS) hospitals routinely ask patients about smoking status on admis…

Provider billing margin and cancer treatment selection: population based cohort study

bmj · abstract · 2025-11-05 · 2 matching annotations

86.6%

National Comprehensive Cancer Network NCCN cancer treatments cancer treatment

…ach patient received among treatment options recommended by the National Comprehensive Cancer Network (NCCN). The characteristics of interest were provider billing m…

1001 In vivo generation of CD19-specific CAR-T cells using a novel AAV gene therapy platform to treat B cell malignancies

jitc · abstract · 2025-11-04 · 2 matching annotations

83.8%

FDA-approved FDA AVO-100 B cell malignancies Raji lymphoma B cell lymphoma AAV CAR-T cell therapies

…afe, off-the-shelf treatment option that is currently used in 7 FDA-approved gene therapies. AVO-100 is a gene therapy that uses AAV with ca…

1118 Deep learning serial CT imaging biomarker for predicting overall survival: a real-world validation in multiple indications of advanced solid tumors treated with immune checkpoint inhibitors

jitc · abstract · 2025-11-04 · 2 matching annotations

86.8%

European Union Providence Health System West Cancer Center metastatic melanoma aNSCLC PD-L1 ICIs immune checkpoint inhibitors (ICIs)ES-SCLC advanced non-small cell lung cancer kidney cancer+3 more

…ction Regulation requirements (European Union). For data in the European Union, the patients were also notified that their deidentified data w…

1122 Identifying critical features of tumor responsiveness to PD-1 immunotherapy using mathematical and biological models

jitc · abstract · 2025-11-04 · 2 matching annotations

82.8%

NSF-GRFP fellowship R01 Diversity Supplement nivolumab University of California Irvine advanced melanoma ipilimumab Chao Family Comprehensive Cancer Center melanoma Melanoma-intrinsic PD-1 blockade+3 more

…vine). R.S.S. is supported by a R01 Diversity Supplement and an NSF-GRFP fellowship.References Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL…

Browse funders

All extracted funders

Articles mentioning funders